Publicaciones en colaboración con investigadores/as de Duke Clinical Research Institute (5)

2024

  1. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review

    Journal of the American College of Cardiology, Vol. 83, Núm. 3, pp. 444-465

2023

  1. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

    Thrombosis Research, Vol. 222, pp. 31-39

2022

  1. Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review

    JAMA Cardiology, Vol. 7, Núm. 7, pp. 747-759

2017

  1. Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy

    Journal of the American Heart Association, Vol. 6, Núm. 7

2016

  1. Extended thromboprophylaxis with betrixaban in acutely ill medical patients

    New England Journal of Medicine, Vol. 375, Núm. 6, pp. 534-544